FRANCIS KNUETTEL II (Interim CEO, CFO, Treas & Sec) reported 2 transactions at PELTHOS THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/2/2024ACC: 0001753926-24-001211
Officer· Interim CEO, CFO, Treas & Sec
Since Feb 2024
-20K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5K
Price / share
—
Trade value
—
% of position
0.9%
6/28/2024
535.51K→530.51K
Common Stock
Direct
Shares
−15K
Price / share
—
Trade value
—
% of position
2.8%
6/28/2024
530.51K→515.51K
Total
Net shares
−20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/28/2024 | G · Gift | −5K | — | — | 0.9% | 535.51K | 530.51K |
| Common Stock Direct | 6/28/2024 | G · Gift | −15K | — | — | 2.8% | 530.51K | 515.51K |
| Total | −20K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported